Valuation: Strides Pharma Science Limited

Market Cap 10TCr 105.07Cr 94Cr 88Cr 80Cr 150.01Cr 150.94Cr 1.06TCr 413.11Cr 5.19TCr 394.48Cr 385.93Cr 17TCr P/E 2027 *
15.9x
P/E 2028 * 11.4x
Enterprise Value 10TCr 105.07Cr 94Cr 88Cr 80Cr 150.01Cr 150.94Cr 1.06TCr 413.11Cr 5.19TCr 394.48Cr 385.93Cr 17TCr EV / Sales 2027 *
1.72x
EV / Sales 2028 * 1.45x
Free-Float
68.12%
Yield 2027 *
0.28%
Yield 2028 * 0.28%
1 day-1.26%
1 week-1.44%
Current month-3.01%
1 month-8.59%
3 months+1.37%
6 months+8.24%
Current year+20.15%
1 week 1,065
Extreme 1065
1,105.4
1 month 1,065
Extreme 1065
1,260.1
Current year 769.6
Extreme 769.6
1,260.1
1 year 769.6
Extreme 769.6
1,260.1
3 years 467.4
Extreme 467.4
1,675.25
5 years 263.45
Extreme 263.45
1,675.25
10 years 263.45
Extreme 263.45
1,675.25
Manager TitleAgeSince
Chief Executive Officer - 01/06/2024
Director of Finance/CFO 42 01/06/2024
Chief Tech/Sci/R&D Officer - 21/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member - 18/05/2017
Director/Board Member 82 18/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.26%-1.44% - - 106.38Cr
+3.62%+1.68%+48.80%+98.41% 1,04000Cr
+2.13%-1.76%+33.04%+61.88% 60TCr
+3.32%+4.47%+23.72%+91.59% 48TCr
+3.80%+3.21%+73.99%+41.69% 35TCr
+3.09%+3.03%+29.59%+45.42% 35TCr
+2.82%+2.20%+17.90%+40.15% 27TCr
+3.40%+0.99%-3.44%+12.08% 24TCr
+3.21%+3.15%+45.01%+49.99% 22TCr
+3.80%+4.56%+29.59%+97.73% 18TCr
Average +2.59%+1.90%+33.13%+59.88% 41.59TCr
Weighted average by Cap. +2.66%+1.53%+36.79%+68.68%

Financials

2027 *2028 *
Net sales 5.82TCr 61Cr 55Cr 51Cr 47Cr 87Cr 88Cr 616.14Cr 240.58Cr 3.02TCr 229.73Cr 224.75Cr 9.72TCr 6.91TCr 73Cr 65Cr 61Cr 55Cr 103.7Cr 104.35Cr 731.4Cr 285.59Cr 3.59TCr 272.7Cr 266.8Cr 12TCr
Net income 627.73Cr 6.6Cr 5.93Cr 5.53Cr 5.02Cr 9.42Cr 9.48Cr 66Cr 26Cr 325.8Cr 25Cr 24Cr 1.05TCr 879.8Cr 9.25Cr 8.31Cr 7.76Cr 7.03Cr 13Cr 13Cr 93Cr 36Cr 456.62Cr 35Cr 34Cr 1.47TCr
Net Debt - -
Projected Income Statement - Annual - Strides Pharma Science Limited
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,535
Date Price Change Volume
14/26/14 ₹1,084.20 -1.26% 5,898
13/26/13 ₹1,098.05 +0.18% 12,451
12/26/12 ₹1,096.05 +1.19% 2,632
09/26/09 ₹1,083.20 -1.09% 9,598
08/26/08 ₹1,095.15 -0.45% 9,435
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Strides Pharma Science Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,084.80INR
Average target price
1,338.67INR
Spread / Average Target
+23.40%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Strides Pharma Science Limited